1. Control of Biohazards: A High Performance Energetic Polycyclized Iodine-Containing Biocide
   Gang Zhao et al, 2018, Inorganic Chemistry CrossRef
2. Platelets in COVID-19: “innocent by-standers” or active participants?
   O. I. An et al, 2021, Pediatric Hematology/Oncology and Immunopathology CrossRef
3. Evaluation of hematological indices in terms of COVID-19 related mortality and ICU admission
   Özgür YILDIRIM et al, 2021, Journal of Health Sciences and Medicine CrossRef
4. The Importance of neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, and thrombocyte-lymphocyte ratio in addition to abnormal laboratory parameters in COVID-19 pneumonia
   Nermin KENİ BEGENDİ et al, 2021, Ege Tıp Dergisi CrossRef
5. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review
   Tissa Wijeratne et al, 2021, Frontiers in Neurology CrossRef
6. Current knowledge of thrombocytopenia in sepsis and COVID-19
   Junjie Cheng et al, 2023, Frontiers in Immunology CrossRef
7. Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019
   Xiao-Yong Zhan et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
8. Coronavirus Pandemic: Role of Bats And Zoonotic Transmission in Humans
   Baljinder Singh et al, 2021, Coronaviruses CrossRef
9. Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department
   Antonio Giovanni Solimando et al, 2021, Frontiers in Medicine CrossRef
10. Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 2019
    Giuseppe Lippi et al, 2021, Acta Haematologica CrossRef
11. Temporal Associations of the SARS-CoV-2 NP Antigen and Anti-Spike Total Ig Levels with Laboratory Parameters in a Greek Cohort of Hospitalized COVID-19 Patients
    Erasmia Rouka et al, 2021, Canadian Respiratory Journal CrossRef
12. SARS-CoV-2 Variants, Vaccines, and Host Immunity
    Priyal Mistry et al, 2022, Frontiers in Immunology CrossRef
13. Phytochemicals as Potential Therapeutics for SARS-CoV-2–Induced Cardiovascular Complications: Thrombosis and Platelet Perspective
    Samir K. Beura et al, 2021, Frontiers in Pharmacology CrossRef
14. Система гемостаза при COVID-19, "Природа"
    А.А. Филькова et al, 2020, Priroda CrossRef
15. A biological profile for diagnosis and outcome of COVID-19 patients
    Mehdi Khourssaji et al, 2020, Clinical Chemistry and Laboratory Medicine (CCLM) CrossRef
16. Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes
    Vasiliki E. Georgakopoulou et al, 2022, Frontiers in Medicine CrossRef
17. Biogenesis aberration: One of the mechanisms of thrombocytopenia in COVID-19
    Cuiting Shan et al, 2023, Frontiers in Physiology CrossRef
18. Hematological Changes in the Second Wave of SARS-CoV-2 in North India
    Akanksha Singh et al, 2022, Cureus CrossRef
19. Predicting Disease Severity and Outcome in COVID-19 Patients: A Review of Multiple Biomarkers
    Youley Tjendra et al, 2020, Archives of Pathology & Laboratory Medicine CrossRef
20. COVID-19 associated coagulopathy is correlated with increased age and markers of inflammation response
    Laurentiu Stratan et al, 2021, Revista Romana de Medicina de Laborator CrossRef
21. Prognostic Value of C-Reactive Protein to Lymphocyte Ratio (CLR) in Emergency Department Patients with SARS-CoV-2 Infection
    Ndenga Tonduangu et al, 2021, Journal of Personalized Medicine CrossRef
22. Comparison of Hematological and Biochemical Parameters of SARS-CoV-2-Positive and -Negative Neonates of COVID-19 Mothers in a COVID-19 Hospital, Odisha State
    Santosh K Panda et al, 2022, Cureus CrossRef
23. Hemostatic laboratory derangements in COVID-19 with a focus on platelet count
    Ariunzaya Amgalan et al, 2020, Platelets CrossRef